Aras Azadian

Aras co-founded Avicanna with the vision of establishing an international biopharmaceutical company with a strict focus on medical and pharmaceutical applications of naturally derived medicines including cannabinoids. His experience in the biotechnology and management consulting have been integral to Avicanna’s thought leadership and progress pertaining to R&D and clinical development of cannabinoid-based products and the commercialization of the company’s extensive pipeline of proprietary products. Since 2016 Aras has successfully led a team of executives and scientists to navigate the complex, and regulated cannabis industry across several international markets with focus on scientific data and an evidence-based approach to product development. Aras holds International master’s in management degree from EADA Business School in Barcelona, Spain and a Bachelor of Economics degree from York University.